SCHEMBL20174446

SCHEMBL20174446

c1ccc(-c2nc(-c3cccc4c3C3(c5ccccc5-4)c4ccccc4-c4sc5ccccc5c43)cc(-c3cccc4ccccc34)n2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
KDM4E B2RXH2 2/20 0.36
ALDH1A1 P00352 2/20 0.36
HPGD P15428 2/20 0.36
TP53 P04637 1/20 0.36
TSHR P16473 1/20 0.36
NFKB1 P19838 1/20 0.36
MAPK1 P28482 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36
ATM Q13315 1/20 0.36
HSD17B10 Q99714 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
RAB9A P51151 2/20 0.32
NPC1 O15118 1/20 0.32
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20174461 0.91 MAPT (0.34) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL20174442 0.90 MEN1 (0.36) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL20174732 0.89 MAPT (0.37) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL20174465 0.89 KDM4E (0.34) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL20174463 0.88 KDM4E (0.35) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL20174451 0.88 MEN1 (0.34) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL20174453 0.86 MEN1 (0.33) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL20174501 0.85 MEN1 (0.37) MAPTKDM4EALDH1A1HPGDMEN1
SCHEMBL20174496 0.85 CYP1A1 (0.38) MAPTSMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL20179276 0.84 CYP1A1 (0.34) MAPTKDM4EALDH1A1HPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-24 US disclosed
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, NR2E3, ERG MAPT 811/4885SMN1; SMN2 3407/4885KDM4E 3633/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.